{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:35:44Z","timestamp":1792089344273,"version":"4.4.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T00:00:00Z","timestamp":1749859200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Huzhou Science and Technology Plan Project","award":["2024GY14"],"award-info":[{"award-number":["2024GY14"]}]},{"name":"Leading Talent Project of Jiangsu Province Traditional Chinese Medicine","award":["SLJ0216"],"award-info":[{"award-number":["SLJ0216"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ijbiomac.2025.145221","type":"journal-article","created":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T02:25:23Z","timestamp":1749867923000},"page":"145221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"P3","title":["pPB peptide-modified nanostructured lipid carriers loaded with astragaloside IV as a potential strategy for enhanced antifibrosis therapy"],"prefix":"10.1016","volume":"319","author":[{"given":"Shasha","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanzhong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.ijbiomac.2025.145221_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25147873","article-title":"Liver fibrosis: from basic science towards clinical progress, focusing on the central role of hepatic stellate cells","volume":"25","author":"Akk\u0131z","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.145221_bb0010","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"Kisseleva","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ijbiomac.2025.145221_bb0015","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","article-title":"Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues","volume":"65","author":"Parola","year":"2019","journal-title":"Mol. Asp. Med."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.145221_bb0020","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.32299","article-title":"A strategy of vascular-targeted therapy for liver fibrosis","volume":"76","author":"Lin","year":"2022","journal-title":"Hepatology"},{"issue":"1 Suppl","key":"10.1016\/j.ijbiomac.2025.145221_bb0025","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0168-8278(00)80413-4","article-title":"New aspects of hepatic fibrosis","volume":"32","author":"Brenner","year":"2000","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145221_bb0030","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1478-3231.2005.01192.x","article-title":"Therapeutic strategies against TGF-beta signaling pathway in hepatic fibrosis","volume":"26","author":"Liu","year":"2006","journal-title":"Liver Int."},{"issue":"10308","key":"10.1016\/j.ijbiomac.2025.145221_bb0035","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","article-title":"Liver cirrhosis","volume":"398","author":"Gin\u00e8s","year":"2021","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.145221_bb0040","doi-asserted-by":"crossref","first-page":"e70058","DOI":"10.1111\/liv.70058","article-title":"Global burden of major chronic liver diseases in 2021","volume":"45","author":"Feng","year":"2025","journal-title":"Liver Int."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145221_bb0045","doi-asserted-by":"crossref","first-page":"e2454707","DOI":"10.1001\/jamanetworkopen.2024.54707","article-title":"Estimated burden of metabolic dysfunction-associated steatotic liver disease in US adults, 2020 to 2050","volume":"8","author":"Le","year":"2025","journal-title":"JAMA Netw. Open"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.145221_bb0050","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/hep4.1899","article-title":"Prevalence and risk factors of advanced liver fibrosis in a population-based study in Germany","volume":"6","author":"Huber","year":"2022","journal-title":"Hepatol. Commun."},{"issue":"23","key":"10.1016\/j.ijbiomac.2025.145221_bb0055","doi-asserted-by":"crossref","first-page":"7260","DOI":"10.3748\/wjg.v20.i23.7260","article-title":"Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: an update","volume":"20","author":"Elpek","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.145221_bb0060","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1478-3231.2007.01469.x","article-title":"Liver fibrosis: searching for cell model answers","volume":"27","author":"Guti\u00e9rrez-Ruiz","year":"2007","journal-title":"Liver Int."},{"key":"10.1016\/j.ijbiomac.2025.145221_bb0065","doi-asserted-by":"crossref","first-page":"122547","DOI":"10.1016\/j.lfs.2024.122547","article-title":"The evidence-based multifaceted roles of hepatic stellate cells in liver diseases: a concise review","volume":"344","author":"Kim","year":"2024","journal-title":"Life Sci."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.145221_bb0070","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/hep.31848","article-title":"Perivenous stellate cells are the main source of myofibroblasts and cancer-associated fibroblasts formed after chronic liver injuries","volume":"74","author":"Wang","year":"2021","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.145221_bb0075","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nrgastro.2010.97","article-title":"Evolving challenges in hepatic fibrosis","volume":"7","author":"Friedman","year":"2010","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ijbiomac.2025.145221_bb0080","doi-asserted-by":"crossref","first-page":"115625","DOI":"10.1016\/j.biopha.2023.115625","article-title":"The potential molecular pathways of astragaloside-IV in colorectal cancer: a systematic review","volume":"167","author":"Ziyang","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"16","key":"10.1016\/j.ijbiomac.2025.145221_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28166118","article-title":"Pharmacological effects of astragaloside IV: a review","volume":"28","author":"Liang","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2025.145221_bb0090","doi-asserted-by":"crossref","first-page":"1131635","DOI":"10.3389\/fphar.2023.1131635","article-title":"Fufang shenhua tablet, astragali radix and its active component astragaloside IV: research progress on anti-inflammatory and immunomodulatory mechanisms in the kidney","volume":"14","author":"Li","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.145221_bb0095","first-page":"3741","article-title":"Astragaloside IV regulates NF-\u03baB-mediated cellular senescence and apoptosis of hepatic stellate cells to suppress PDGF-BB-induced activation","volume":"18","author":"Chen","year":"2019","journal-title":"Exp. Ther. Med."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.145221_bb0100","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1080\/17425247.2024.2410951","article-title":"Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for the delivery of bioactives sourced from plants: part I \u2014 composition and production methods","volume":"21","author":"Fathi","year":"2024","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijbiomac.2025.145221_bb0105","doi-asserted-by":"crossref","first-page":"8091","DOI":"10.2147\/IJN.S478964","article-title":"Advancements and challenges of nanostructured lipid carriers for wound healing applications","volume":"19","author":"Wathoni","year":"2024","journal-title":"Int. J. Nanomedicine"},{"issue":"49","key":"10.1016\/j.ijbiomac.2025.145221_bb0110","doi-asserted-by":"crossref","first-page":"15827","DOI":"10.1021\/acs.nanolett.4c04820","article-title":"Hepatic stellate cell membrane-camouflaged nanoparticles for targeted delivery of an antifibrotic agent to hepatic stellate cells with enhanced antifibrosis efficacy","volume":"24","author":"Cheng","year":"2024","journal-title":"Nano Lett."},{"key":"10.1016\/j.ijbiomac.2025.145221_bb0115","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jconrel.2024.10.044","article-title":"Hepatic stellate cell-targeted chemo-gene therapy for liver fibrosis using fluorinated peptide-lipid hybrid nanoparticles","volume":"376","author":"Lai","year":"2024","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.145221_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14051108","article-title":"Reparative efficacy of liposome-encapsulated Oleanolic acid against liver inflammation induced by fine ambient particulate matter and alcohol in mice","volume":"14","author":"Wei","year":"2022","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.145221_bb0125","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4196\/kjpp.24.309","article-title":"Roles of PDGF\/PDGFR signaling in various organs","volume":"29","author":"Jung","year":"2025","journal-title":"Kor. J. Physiol. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.145221_bb0130","doi-asserted-by":"crossref","first-page":"1341020","DOI":"10.3389\/fphar.2024.1341020","article-title":"Quantitative proteomics reveals the protective effects of Yinchenzhufu decoction against cholestatic liver fibrosis in mice by inhibiting the PDGFR\u03b2\/PI3K\/AKT pathway","volume":"15","author":"Meng","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145221_bb0135","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jhep.2015.01.036","article-title":"\u03b2-PDGF receptor expressed by hepatic stellate cells regulates fibrosis in murine liver injury, but not carcinogenesis","volume":"63","author":"Kocabayoglu","year":"2015","journal-title":"J. Hepatol."},{"issue":"Pt 1","key":"10.1016\/j.ijbiomac.2025.145221_bb0140","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1042\/bj2810057","article-title":"Purification and analysis of proteinase-resistant mutants of recombinant platelet-derived growth factor-BB exhibiting improved biological activity","volume":"281","author":"Cook","year":"1992","journal-title":"Biochem. J."},{"key":"10.1016\/j.ijbiomac.2025.145221_bb0145","doi-asserted-by":"crossref","first-page":"123295","DOI":"10.1016\/j.biomaterials.2025.123295","article-title":"Modification of MSCs with aHSCs-targeting peptide pPB for enhanced therapeutic efficacy in liver fibrosis","volume":"321","author":"Yuan","year":"2025","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.145221_bb0150","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1021\/acsnano.0c02633","article-title":"Liver-targeted siRNA lipid nanoparticles treat hepatic cirrhosis by dual antifibrotic and anti-inflammatory activities","volume":"14","author":"Zhang","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijbiomac.2025.145221_bb0155","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jconrel.2018.12.039","article-title":"The antifibrotic potential of a sustained release formulation of a PDGF\u03b2-receptor targeted rho kinase inhibitor","volume":"296","author":"van Dijk","year":"2019","journal-title":"J. Control. Release"},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2025.145221_bb0160","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ijpharm.2013.02.054","article-title":"Astragaloside IV-loaded nanoparticle-enriched hydrogel induces wound healing and anti-scar activity through topical delivery","volume":"447","author":"Chen","year":"2013","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145221_bb0165","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12967-025-06135-9","article-title":"UBE2J1 is identified as a novel plasma cell-related gene involved in the prognosis of high-grade serous ovarian cancer","volume":"23","author":"Tian","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ijbiomac.2025.145221_bb0170","doi-asserted-by":"crossref","first-page":"118623","DOI":"10.1016\/j.carbpol.2021.118623","article-title":"New synthetic adriamycin-incorporated chitosan nanoparticles with enhanced antioxidant, antitumor activities and pH-sensitive drug release","volume":"273","author":"Mi","year":"2021","journal-title":"Carbohydr. Polym."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.145221_bb0175","doi-asserted-by":"crossref","first-page":"20739","DOI":"10.1021\/acsnano.2c07796","article-title":"Reactive oxygen species-responsive polypeptide drug delivery system targeted activated hepatic stellate cells to ameliorate liver fibrosis","volume":"16","author":"Hao","year":"2022","journal-title":"ACS Nano"},{"issue":"766","key":"10.1016\/j.ijbiomac.2025.145221_bb0180","doi-asserted-by":"crossref","first-page":"eadk8446","DOI":"10.1126\/scitranslmed.adk8446","article-title":"Inhibition of heme-thiolate monooxygenase CYP1B1 prevents hepatic stellate cell activation and liver fibrosis by accumulating trehalose","volume":"16","author":"Tung","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ijbiomac.2025.145221_bb0185","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.actbio.2023.06.032","article-title":"CREKA-modified liposomes target activated hepatic stellate cells to alleviate liver fibrosis by inhibiting collagen synthesis and angiogenesis","volume":"168","author":"Li","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ijbiomac.2025.145221_bb0190","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jconrel.2019.04.022","article-title":"An integrin-based nanoparticle that targets activated hepatic stellate cells and alleviates liver fibrosis","volume":"303","author":"Li","year":"2019","journal-title":"J. Control. Release"},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.145221_bb0195","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1111\/1750-3841.15379","article-title":"The potential application of the protein hydrolysates of three medicinal plants: cytotoxicity and functional properties","volume":"85","author":"Taghizadeh","year":"2020","journal-title":"J. Food Sci."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.145221_bb0200","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1080\/07388551.2024.2412780","article-title":"Enhancing cyclotide bioproduction: harnessing biological synthesis methods and various expression systems for large-scale manufacturing","volume":"45","author":"Taghizadeh","year":"2025","journal-title":"Crit. Rev. Biotechnol."},{"issue":"16","key":"10.1016\/j.ijbiomac.2025.145221_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/polym14163371","article-title":"Impact of whey protein edible coating containing fish gelatin hydrolysates on physicochemical, microbial, and sensory properties of chicken breast fillets","volume":"14","author":"Sabzipour-Hafshejani","year":"2022","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.ijbiomac.2025.145221_bb0210","doi-asserted-by":"crossref","first-page":"104777","DOI":"10.1016\/j.bioorg.2021.104777","article-title":"Novel bioactive peptides of Achillea eriophora show anticancer and antioxidant activities","volume":"110","author":"Taghizadeh","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.145221_bb0215","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1080\/07388551.2024.2412780","article-title":"Enhancing cyclotide bioproduction: harnessing biological synthesis methods and various expression systems for large-scale manufacturing","volume":"45","author":"Taghizadeh","year":"2025","journal-title":"Crit. Rev. Biotechnol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.145221_bb0220","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/bab.2158","article-title":"Successful use of Nicotiana tabacum hairy roots for the recombinant production of Cecropin A peptide","volume":"69","author":"Hashemi","year":"2022","journal-title":"Biotechnol. Appl. Biochem."},{"key":"10.1016\/j.ijbiomac.2025.145221_bb0225","doi-asserted-by":"crossref","first-page":"1327820","DOI":"10.3389\/fphar.2024.1327820","article-title":"Structure-guided design and cloning of peptide inhibitors targeting CDK9\/cyclin T1 protein-protein interaction","volume":"15","author":"Taghizadeh","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.145221_bb0230","doi-asserted-by":"crossref","first-page":"9215","DOI":"10.1038\/s41598-022-13142-z","article-title":"Discovery of the cyclotide caripe 11 as a ligand of the cholecystokinin-2 receptor","volume":"12","author":"Taghizadeh","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.145221_bb0235","first-page":"100440","article-title":"Virus-like particles (VLPs): a promising platform for combating against Newcastle disease virus","volume":"16","author":"Taghizadeh","year":"2024","journal-title":"Vacc. X"},{"issue":"23","key":"10.1016\/j.ijbiomac.2025.145221_bb0240","doi-asserted-by":"crossref","first-page":"e40636","DOI":"10.1016\/j.heliyon.2024.e40636","article-title":"Unveiling the insecticidal efficiency of Viola ignobilis against Macrosiphum rosae and Agonoscena pistaciae: from chemical composition to cytotoxicity analysis","volume":"10","author":"Taghizadeh","year":"2024","journal-title":"Heliyon"}],"updated-by":[{"DOI":"10.1016\/j.ijbiomac.2025.146243","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000}}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025057745?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025057745?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T02:13:54Z","timestamp":1770776034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025057745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":48,"alternative-id":["S0141813025057745"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.145221","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"pPB peptide-modified nanostructured lipid carriers loaded with astragaloside IV as a potential strategy for enhanced antifibrosis therapy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.145221","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"145221"}}